SCHEMBL18304652

SCHEMBL18304652

COc1cc(C(=O)O)cc(-c2ccco2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.61
KEAP1 Q14145 1/20 0.60
EP300 Q09472 2/20 0.52
CREBBP Q92793 2/20 0.52
BAZ2B Q9UIF8 2/20 0.52
RXRA P19793 1/20 0.51
NR4A2 P43354 1/20 0.50
ERN1 O75460 1/20 0.47
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 2/20 0.47
TSHR P16473 1/20 0.47
HPGD P15428 3/20 0.46
PTPN1 P18031 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18311307 0.87 KAT6A (0.57) KAT6AKEAP1EP300CREBBPBAZ2B
SCHEMBL5924902 0.85 KEAP1 (0.74) KAT6AKEAP1EP300CREBBPBAZ2B
SCHEMBL31151058 0.85 KEAP1 (0.74) KAT6AKEAP1EP300CREBBPBAZ2B
SCHEMBL2385998 0.82 ALDH1A1 (0.53) KAT6AERN1ALDH1A1KDM4EMEN1
SCHEMBL18304663 0.81 KEAP1 (0.64) KAT6AKEAP1EP300CREBBPBAZ2B
SCHEMBL14150399 0.79 RXRA (0.69) RXRAMEN1KMT2APOLBNPC1
SCHEMBL30420728 0.79 RXRA (0.69) RXRAMEN1KMT2APOLBNPC1
SCHEMBL18304656 0.78 KEAP1 (0.64) KAT6AKEAP1EP300CREBBPBAZ2B
SCHEMBL18304658 0.78 KEAP1 (0.64) KAT6AKEAP1EP300CREBBPBAZ2B
SCHEMBL2723466 0.78 KEAP1 (0.64) KAT6AKEAP1EP300CREBBPBAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307258-B1 ARYL SULFONOHYDRAZIDES UNIV MONASH (AU) 2020-12-16 EP disclosed
EP-3307258-B1 ARYL SULFONOHYDRAZIDES UNIV MONASH (AU) 2020-12-16 EP disclosed
US-10829446-B2 Aryl sulfonohydrazides MONASH UNIVERSITY (AU) 2020-11-10 US disclosed
US-10829446-B2 Aryl sulfonohydrazides MONASH UNIVERSITY (AU) 2020-11-10 US disclosed
US-20180222857-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2018-08-09 US disclosed
US-20180222857-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2018-08-09 US disclosed
US-20180222857-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2018-08-09 US disclosed
EP-3307258-A1 ARYL SULFONOHYDRAZIDES Monash University (AU) 2018-04-18 EP disclosed
WO-2016198507-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2016-12-15 WO disclosed
WO-2016198507-A1 ARYL SULFONOHYDRAZIDES MONASH UNIVERSITY (AU) 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222857-A1 ARYL SULFONOHYDRAZIDES FPR3, NCOA3, HAT1 KAT6A 130/4885KEAP1 2018/4885EP300 51/4885
US-10829446-B2 Aryl sulfonohydrazides FPR3, NCOA3, HAT1 KAT6A 130/4885KEAP1 2018/4885EP300 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.